|
|
|
|
|
|
March 13, 2026
|
Alberta Securities Commission |
British Columbia Securities Commission |
Ontario Securities Commission |
RE: Xenon Pharmaceuticals Inc.
Pursuant to a request from the above-mentioned reporting issuer, we wish to advise you of the following information in connection with its Annual Meeting of Shareholders:
|
|
Date of meeting: |
June 2, 2026 |
Record date for notice: |
April 7, 2026 |
Record date for voting: |
April 7, 2026 |
Beneficial ownership determination date: |
April 7, 2026 |
Securities entitled to notice: |
Common Shares |
Securities entitled to vote: |
Common Shares |
Issuer mailing directly to non-objecting beneficial owners: |
No |
Issuer will pay for objecting beneficial owner material distribution: |
Yes |
Issuer using notice-and-access for registered investors: |
Yes |
Issuer using notice-and-access for non-registered investors: |
Yes |
Notice-and-access stratification criteria: |
N/A |
Thank you!
Shelby Behr
Client Success Manager
+1 (919) 410-4412 W
shelby.behr@betanxt.com
Mediant, a BetaNXT business